Crossmark

Multimodal digital health treatments for Chronic Migraine associated with Medication Overuse Headache: a literature appraisal and results of a single-arm open trial (the BE-HOME program)

Crossref DOI link: https://doi.org/10.1007/s10072-024-07568-8

Published Online: 2024-05-21

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Grazzi, Licia https://orcid.org/0000-0001-6535-1109
Montisano, Danilo Antonio https://orcid.org/0000-0003-4834-2045
D’Amico, Domenico https://orcid.org/0000-0002-5016-9301
Altamura, Claudia https://orcid.org/0000-0002-5934-5535
Raggi, Alberto https://orcid.org/0000-0002-7433-7779
Rizzoli, Paul https://orcid.org/0000-0001-7278-3110
Marcassoli, Alessia https://orcid.org/0000-0002-5003-1409
License Information

Text and Data Mining valid from 2024-05-21

Version of Record valid from 2024-05-21
More Information

Article History

Received: 26 February 2024

Accepted: 24 April 2024

First Online: 21 May 2024

Declarations

:

: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Fondazione IRCCS Istituto Neurologico Carlo Besta (approval no. 75.01/2020).

: Informed consent was obtained from all individual participants included in the study.

: CA received travel grants and honoraria from Eli Lilly, TeVA, Abbvie, Lundbeck.

Document is current

Any future updates will be listed below